Showing 1 - 10 of 27
expenditure is of course influenced by policy and also by problems and inefficiencies on the market for pharmaceuticals production …
Persistent link: https://www.econbiz.de/10011114476
This third overview of EU competition and sector-specific regulatory jurisprudential and case law developments with a nexus to Poland covers the years 2010 and 2011. This period of time is worth noting for several reasons. First, EU courts delivered a significant number of judgments in...
Persistent link: https://www.econbiz.de/10011260409
Persistent link: https://www.econbiz.de/10008520728
dynamics of original products are affected by generic competition. Our empirical investigation shows that the dynamics of drug … distinction seems to emerge. On the one hand, systems that rely on market-based competition in pharmaceuticals promote a clear …
Persistent link: https://www.econbiz.de/10005034975
, and the activities of Shaman Pharmaceuticals in Latin America and Africa. It provides the details, discusses what each …
Persistent link: https://www.econbiz.de/10005621738
Within the debate about the rise of costs in the German health system, the argument has put forth that patients' excessive demand for benefits is caused by the existence of a moral hazard problem. One way of influencing an insured person's consumer behaviour is the introduction of several...
Persistent link: https://www.econbiz.de/10008765092
monopolistic manufacturer of pharmaceuticals and a foreign exclusive distributor we, first, show that parallel trade reduces the …
Persistent link: https://www.econbiz.de/10011107968
. Foreign-owned firms tend to be large, and thus the decisive share of BERD is performed by large enterprises. Pharmaceuticals … past fifteen years as foreign pharmaceuticals firms became majority owners in most companies, pursuing global R …
Persistent link: https://www.econbiz.de/10011113727
We consider a policy game between a high-income country hosting a drug innovator and a low-income country hosting a … drug imitator. The low-income country chooses whether to enforce an International Patent Regime (strict IPR) or not (weak …
Persistent link: https://www.econbiz.de/10011115487
We analyze the influence of technological progress on pharmaceuticals on rising health expenditures using US State …
Persistent link: https://www.econbiz.de/10005790100